Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
April 11, 2023	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-23-097795.pdf 0001193125-23-097795.rtf View HTML
April 14, 2023	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-23-101547.pdf 0001193125-23-101547.rtf View HTML
April 14, 2023	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-23-102245.pdf 0001193125-23-102245.rtf View HTML
April 21, 2023	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-23-110580.pdf 0001193125-23-110580.rtf View HTML
April 25, 2023	8-K	Report of unscheduled material events or corporate event	0001193125-23-115513.pdf 0001193125-23-115513.rtf 0001193125-23-115513.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
April 28, 2023	8-K	Report of unscheduled material events or corporate event	0001193125-23-124259.pdf 0001193125-23-124259.rtf 0001193125-23-124259.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
April 28, 2023	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001193125-23-124284.pdf 0001193125-23-124284.rtf 0001193125-23-124284.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
April 28, 2023	ARS	An annual report to security holders	0001193125-23-125003.pdf 0001193125-23-125003.rtf View HTML
May 8, 2023	8-K	Report of unscheduled material events or corporate event	0001193125-23-137689.pdf 0001193125-23-137689.rtf 0001193125-23-137689.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
May 8, 2023	8-K	Report of unscheduled material events or corporate event	0001193125-23-137688.pdf 0001193125-23-137688.rtf 0001193125-23-137688.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax